On the TechTO stage ×1
First seen on the TechTO stage in 2018. Every talk is searchable — ask the archive about Anthony ↗
In their words
We can actually sequence antibodies directly from the protein itself. It's very similar to DNA sequencing, except we don't need the DNA, we just need the actual antibody itself.
We are the first company to actually commercially offer full protein sequencing, and this is an innovation from us that happened locally.
Our company is the product of Dr. Ben Ma, a tenured professor at the University of Waterloo in the mathematics department, who previously founded a different company called Bioinformatics Solutions.
Quick answers
Who is Anthony Stajduhar?
Global director of business development at Rapid Novor, a Kitchener, Ontario antibody protein-sequencing company. He presented the company at TechTO's HealthTO event in August 2018.
What does Rapid Novor do?
It sequences antibodies directly from the protein itself, rather than from DNA, on a contract basis for pharmaceutical and research clients. It was the first company to commercially offer full protein sequencing.